Wilson Sonsini advised Replay on the deal.Replay, a genome writing company reprogramming biology by writing and delivering big DNA, announced its launch with $55 million in…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
